profit from every $100 of sales.

Tenet Healthcare
Trading close to its highest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2020 to 2025.
You pay $16.42 for every $1 of profit it makes in a year.
of earnings would pay off all its debt.
Money in, money out
What Tenet Healthcare sold, what it kept, and what it did with the cash.
Sales went from $19.2 billion in 2022 to $21.3 billion in 2025, with $1.41 billion of profit last year.
Tenet Healthcare handed back 55% of the cash it generated last year.
Tenet Healthcare vs. similar companies
Tenet Healthcare grows in the middle of these 5 and is priced in the middle for its profits.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
Tenet Healthcare | 16.4× · Fair price | ||
Solventum | 9.8× · Cheap | ||
Encompass Health | 24.7× · Fair price | ||
Fresenius Medical Care AG & Co. KGaA | 10.8× · Cheap | ||
DaVita | 15.1× · Fair price |
Compare Tenet Healthcare with HCA Healthcare
AI analysis
An AI analyst reads Tenet Healthcare's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 17,640 | 19,485 | 19,174 | 20,564 | 20,675 | 21,310 | |
| – | – | 15,901 | 16,974 | 17,028 | 17,530 | |
| 1,989 | 2,871 | 2,412 | 2,443 | 2,917 | 3,439 | |
| 2,531 | 3,666 | 3,076 | 3,388 | 6,892 | 4,484 | |
| 399 | 914 | 411 | 611 | 3,200 | 1,407 | |
| 3.75 | 8.42 | 3.79 | 5.71 | 32.70 | 15.49 | |
| – | – | 82.9% | 82.5% | 82.4% | 82.3% | |
| 11.3% | 14.7% | 12.6% | 11.9% | 14.1% | 16.1% | |
| 2.3% | 4.7% | 2.1% | 3.0% | 15.5% | 6.6% |
Balance sheet
| In millions of USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Total assets | 27,106 | 27,579 | 27,156 | 28,312 | 28,936 | 29,677 |
| Cash | 2,446 | 2,364 | 858 | 1,228 | 3,019 | 2,883 |
| Total debt | 15,895 | 15,797 | 15,079 | 15,002 | 13,173 | 13,171 |
| Total liabilities | 24,217 | 23,322 | 22,548 | 22,804 | 20,389 | 20,704 |
| 28 | 1,028 | 1,142 | 1,608 | 4,171 | 4,220 | |
| 106 | 109 | 111 | 105 | 98 | 91 | |
| 8.3% | 13.2% | 10.9% | 12.0% | 27.7% | 16.4% | |
| 1,425.0% | 88.9% | 36.0% | 38.0% | 76.7% | 33.3% |
Cash flow
| In millions of USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 3,407 | 1,568 | 1,083 | 2,374 | 2,047 | 3,540 | |
| 540 | 658 | 762 | 751 | 931 | 1,010 | |
| 2,867 | 910 | 321 | 1,623 | 1,116 | 2,530 | |
| Dividends paid | – | – | – | – | – | – |
| 0 | 0 | 250 | 200 | 672 | 1,386 | |
| 44 | 56 | 56 | 66 | 67 | 104 |
Valuation
- 16.4×
- 16.3×
- 0.50
- 3.5×
- 1.1×
- 9.1×
- 7.4×
- 11.0%
- 6.1%
- 0.0%
Profitability
- 82.3%
- 16.1%
- 6.6%
- 20.5%
- 11.5%
- 7.4%
- 40.6%
- 5.5%
- 13.8%
- –
Growth
- +3.9%
- +32.8%
- +126.7%
- –
- −4.2%
Financial health
- 2.3×
- 2.74
- 42.3%
- 4.2×
- 1.36
- 1.30
- 0.69
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
What analysts expect
- Average price target
- $267.11
- Range
- $250.00 – $288.00
- 11 analysts
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| Apr 30, 2026 | 4.82 | 4.21 | +14.5% |
| Feb 11, 2026 | 4.70 | 4.07 | +15.5% |
| Oct 28, 2025 | 3.70 | 3.34 | +10.8% |
| Jul 22, 2025 | 4.02 | 2.87 | +40.1% |
| Apr 29, 2025 | 4.36 | 3.12 | +39.7% |
| Feb 12, 2025 | 3.44 | 2.95 | +16.6% |
| Oct 29, 2024 | 2.93 | 2.33 | +25.8% |
| Jul 24, 2024 | 2.31 | 1.90 | +21.6% |
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
3/7Passes 3 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Questions about Tenet Healthcare
Is Tenet Healthcare a good stock to buy?
A business with weak numbers at a fair price. 3 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Tenet Healthcare AI analysis
What does Tenet Healthcare do?
Tenet Healthcare Corporation operates as a diversified healthcare services company. The company operates in three segments: Hospital Operations and Other, Ambulatory Care, and Conifer. It is in Medical - Care Facilities, based in Dallas, TX, United States, with 77,000 employees.
Does Tenet Healthcare pay a dividend?
No. Tenet Healthcare does not pay a dividend at the moment; in 2025 it returned $1.39 billion to shareholders by buying back its own shares.
Is Tenet Healthcare stock halal?
No. Tenet Healthcare does not pass our halal screen: its debt is 57% of its market value, at or above the 33% limit. How we check
How has Tenet Healthcare stock done over the past year?
Up 49.1% over the past twelve months, to $290.27. It traded between $161.37 and $292.25, close to its high.
Who are Tenet Healthcare's competitors?
The largest listed companies in the same industry are Solventum, Encompass Health, Fresenius Medical Care AG & Co. KGaA and DaVita. The peers table on this page compares their profit, growth and price with Tenet Healthcare's.
Prices: daily closes to Nov 10, 2026. Fundamentals: company reports via invest-like data.



